KR20200035715A - The manufacturing process of the black-ginseng comprising high ginsenoside content - Google Patents
The manufacturing process of the black-ginseng comprising high ginsenoside content Download PDFInfo
- Publication number
- KR20200035715A KR20200035715A KR1020180115177A KR20180115177A KR20200035715A KR 20200035715 A KR20200035715 A KR 20200035715A KR 1020180115177 A KR1020180115177 A KR 1020180115177A KR 20180115177 A KR20180115177 A KR 20180115177A KR 20200035715 A KR20200035715 A KR 20200035715A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- black ginseng
- acid
- black
- aqueous solution
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 36
- 229930182494 ginsenoside Natural products 0.000 title claims abstract description 31
- 229940089161 ginsenoside Drugs 0.000 title abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 114
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 114
- 235000008434 ginseng Nutrition 0.000 claims abstract description 114
- 238000000034 method Methods 0.000 claims abstract description 33
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000001035 drying Methods 0.000 claims abstract description 17
- 238000010025 steaming Methods 0.000 claims abstract description 15
- 241000208340 Araliaceae Species 0.000 claims abstract 24
- 239000002253 acid Substances 0.000 claims description 28
- 239000007864 aqueous solution Substances 0.000 claims description 20
- 235000005979 Citrus limon Nutrition 0.000 claims description 13
- 244000131522 Citrus pyriformis Species 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 5
- 239000011260 aqueous acid Substances 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 11
- 240000004371 Panax ginseng Species 0.000 description 91
- 235000002789 Panax ginseng Nutrition 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 150000007523 nucleic acids Chemical class 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 235000017709 saponins Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 101100120609 Caenorhabditis elegans frh-1 gene Proteins 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000510678 Falcaria vulgaris Species 0.000 description 1
- SWIROVJVGRGSPO-UHFFFAOYSA-N Ginsenoside F2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O SWIROVJVGRGSPO-UHFFFAOYSA-N 0.000 description 1
- AVTXSAWPGCSYFO-UHFFFAOYSA-N Ginsenoside Ia Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O AVTXSAWPGCSYFO-UHFFFAOYSA-N 0.000 description 1
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- -1 Rg2 Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- TXVHTIQJNYSSKO-UHFFFAOYSA-N benzo[e]pyrene Chemical class C1=CC=C2C3=CC=CC=C3C3=CC=CC4=CC=C1C2=C34 TXVHTIQJNYSSKO-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 231100000049 endocrine disruptor Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- SWIROVJVGRGSPO-JBVRGBGGSA-N ginsenoside F2 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SWIROVJVGRGSPO-JBVRGBGGSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000003 human carcinogen Toxicity 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920005547 polycyclic aromatic hydrocarbon Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/13—General methods of cooking foods, e.g. by roasting or frying using water or steam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/38—Multiple-step
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 고함량의 진세노사이드를 함유하는 흑삼의 제조방법에 관한 것으로서, 보다 상세하게는 종래 증숙과 건조의 반복 과정으로 생성되는 유해한 성분인 벤조피렌의 함량은 저감시키고, 진세노사이드 Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 및 Rk1의 함량은 증가시킨 흑삼의 제조방법에 관한 것이다.The present invention relates to a method for producing black ginseng containing a high content of ginsenosides, and more specifically, to reduce the content of benzopyrene, which is a harmful component produced by a repeated process of steaming and drying, and reduces ginsenosides Rh1 and Rh2. , Rg2, Rb1, Rb2, F2, Rg3 and Rk1 are related to the production method of increased black ginseng.
인삼은 두릅나무과에 속하는 다년생 초본(草本:꽃이나 풀 등)식물로 학명은 Panax schinseng NEES이다. 깊은 산악지대에서 자라는 식물이고 현재는 흔히 재배하고 있다. 높이는 60㎝에 달하고, 근경(根莖:뿌리와 줄기)은 짧으며 곧거나 비스듬히 서고, 밑에서 도라지 같은 뿌리가 발달한다. 근경 끝에서 1개의 원줄기가 나오고 끝에서 3, 4개의 잎이 윤생(輪生:돌려나기)하며 긴 엽병 끝에 5개의 장상복엽(掌狀複葉:손바닥 모양의 겹잎)이 달린다.Ginseng is a perennial herbaceous plant belonging to the genus Elmaceae. The scientific name is Panax schinseng NEES. It grows in a deep mountainous region and is now commonly grown. The height reaches 60cm, the root diameter (根莖: root and stem) is short and stands upright or at an angle, and a bellflower-like root develops from the bottom. At the end of the rhizome, one main stem emerges, and 3 or 4 leaves at the end are lubricated (輪 生: protruding), and at the end of the long leaf, 5 long bilobes (掌狀 複葉: palm-shaped double leaves) run.
기존 한방서에는 인삼의 약효로서 강장, 강심, 건위보정(健胃補精), 진정약으로 널리 상용되고, 위장기능 쇠약에 의한 신진대사 기능의 저하에 진흥약(振興藥)으로 사용되며, 병약자의 위부정체감(胃部停滯感), 소화불량, 구토, 흉통(胸痛), 이완성하리(弛緩性下痢), 식욕부진 등에도 응용되는 것으로 알려져 있다.It is widely used as a tonic, gangsim, geonwi correction, sedative medicine as a medicinal effect of ginseng in the existing oriental medicine, and used as a stimulant for deteriorating metabolic function due to gastrointestinal weakness. It is known to be applied to a person's stomach sensation, indigestion, vomiting, chest pain, loosening, and anorexia.
인삼약효의 주성분이라고 현재까지 알려져 있는 진세노사이드 물질은 항피로작용(抗疲勞作用), 작업능력증진작용, 성선(性腺:생식샘)의 발육촉진작용, 혈당치 강하작용 등이 있는 것으로 증명되어 있다.Ginsenosides, which have been known to be the main ingredient of ginseng medicinal efficacy, have been proven to have anti-fatigue action, work capacity enhancement action, growth promoting action of sex glands, and hypoglycemic action.
인삼은 70% 내외의 수분을 함유하고 있으므로 이것을 그대로 저장하거나 운반할 때 부패, 손상되기 쉬워 장기간 저장을 위하여 인삼을 증숙한 뒤 말려 홍삼으로 만든다. 또한, 흑삼은 위와 같은 증숙과 건조 과정을 여러 차례 되풀이하여 얻어지는 것으로서 통상 구증구포(아홉 번 찌고 아홉 번 말림) 공정으로 제조된다. 홍삼, 흑삼 외에도 흑홍삼이 있는데, 이는 흑삼과 홍삼의 중간 제품이다.Ginseng contains about 70% of moisture, so it is easy to decay and damage when it is stored or transported as it is, and it is made into red ginseng after steaming and drying the ginseng for long-term storage. In addition, black ginseng is obtained by repeating the above steaming and drying process several times, and is usually produced by a gujeomgupo (steamed nine times and dried nine times) process. In addition to red ginseng and black ginseng, there are black and red ginseng, which is an intermediate product between black and red ginseng.
홍삼, 흑삼, 흑홍삼 등 열처리 가공삼은 찌고 건조시키는 공정을 거치면서 인삼에 함유되지 않은 진세노사이드가 새로 생성되기도 하며, 원래 진세노사이드의 함량에도 많은 변화가 생기게 된다. 그 결과, 인삼과는 다른 우수한 약리효과를 나타내게 되며, 보존성도 좋아진다. 그리하여 수삼이나 백삼 대신 홍삼, 흑삼, 흑홍삼 등을 이용한 건강기능성 식품, 약학 조성물 등의 개발이 활발히 이루어지고 있다.Heat-treated processed ginseng, such as red ginseng, black ginseng, and black red ginseng, undergoes a process of steaming and drying, and new ginsenosides not contained in ginseng may be newly generated, and the content of ginsenosides in the original may be changed significantly. As a result, it exhibits an excellent pharmacological effect different from that of ginseng, and also improves preservation. Therefore, the development of health functional foods, pharmaceutical compositions, etc. using red ginseng, black ginseng, black red ginseng, etc. instead of ginseng or white ginseng has been actively conducted.
대한민국 등록특허공보 제10-0991351호에는 수삼을 산 처리한 후 4회 이상의 증숙/건조 단계를 거쳐 흑삼을 제조하는 방법이 공지되어 있으며, 대한민국 등록특허공보 제10-0600795호에는 진세노사이드 Rg3의 함량을 증가시키기 위해 수삼을 구증구포 방법으로 흑삼을 제조하는 방법이 기재되어 있고, 대한민국 등록특허공보 제10-0671330호에는 조사포닌의 함량이 증가된 구증구포 방법을 기재하고 있고, 대한민국 등록특허공보 제10-0543862호에는 흑삼을 9회 증숙시키고 10회 황토건조실에서 건조시켜 제조된 흑삼으로써, 일반 흑삼에 비해 특정 진세노사이드 성분의 함량이 높아진 흑삼과 흑삼 농축액에 관한 것이 공개되어 있고, 대한민국 등록특허공보 제10-0529475호에는 인삼을 세척하여 건조 시킨 후 증숙과 건조시키는 과정을 9회 반복하여 사포닌 성분이 증가된 흑삼과 흑미삼의 제조방법에 관한 것이 공개되어 있고, 대한민국 등록특허공보 제10-0496418호에는 대부분의 사포닌을 함유하고 있는 인삼의 잔뿌리를 10증 10포법에 의해 흑미삼을 제조하는 방법에 관한 것이 공개되어 있다.Korean Patent Registration No. 10-0991351 discloses a method of producing black ginseng through at least four steaming / drying steps after acid treatment of ginseng, and in Korean Patent Registration No. 10-0600795, ginsenoside Rg3 In order to increase the content, a method of manufacturing black ginseng with a method of guanggupogu is described, and in Korean Patent Publication No. 10-0671330, a method of guanggupogu with an increased content of irradiated saponin is described. No. 10-0543862, black ginseng prepared by steaming black ginseng 9 times and drying it in the loess drying room 10 times, discloses black ginseng and black ginseng concentrates with higher content of specific ginsenosides than ordinary black ginseng, registered in Korea In Patent Publication No. 10-0529475, the process of steaming and drying ginseng is repeated, and the process of steaming and drying is repeated 9 times to increase the saponin component. A method of manufacturing black ginseng and black ginseng has been published, and Korean Patent Registration No. 10-0496418 discloses a method of manufacturing black rice ginseng by 10-depth and 10-package of the roots of ginseng containing most of the saponins. Things are public.
하지만, 위와 같은 제조방법들은 흑삼의 제조에 소요된 시간이 총 60시간 이상 소요됨으로써 제조 시간이 길어지고, 이로 인해 경제성이 떨어지는 문제점이 있을 뿐만 아니라 증숙과 건조를 반복하는 과정에서 유해한 성분인 벤조피렌이 생성될 우려가 있다.However, the above manufacturing methods take longer than 60 hours for the production of black ginseng, resulting in a longer manufacturing time, which leads to lower economic efficiency, as well as the harmful component of benzopyrene in the process of evaporation and drying. It is likely to be generated.
벤조피렌은 다환 방향족 탄화수소(polycyclic aromatichydrocarbon, PAH)에 속하는 황색의 결정성 고체이며, 300~600℃에서 불완전 연소로 생성되는 물질로서, 환경오염 등으로 인해 농산물, 어패류 등 조리하거나 가공하지 않은 식품에도 존재하고 식품을 고온으로 가열할 때 식품의 주성분인 탄수화물, 단백질, 지질 등이 분해되어 생성되기도 한다. 이와 같이, 벤조피렌은 주로 오염된 물, 음식 그리고 대기를 통해 인체에 노출되며, 인체로부터 대사된 다양한 벤조피렌 대사체는 DNA에 내전되어 암을 일으키는 원인으로 알려져 있다.Benzopyrene is a yellow crystalline solid belonging to polycyclic aromatichydrocarbon (PAH) and is produced by incomplete combustion at 300 ~ 600 ℃, and is also present in foods that are not cooked or processed, such as agricultural products, seafood, etc. due to environmental pollution. And when the food is heated to a high temperature, carbohydrates, proteins, lipids, etc., which are the main components of the food, are decomposed. As such, benzopyrene is mainly exposed to the human body through contaminated water, food, and the atmosphere, and various benzopyrene metabolites metabolized from the human body are known to cause cancer due to internalization of DNA.
벤조피렌은 잔류기간이 길고 독성도 강하여 더욱 문제가 되고 있는데 내분비계 장애물질이면서 동시에 발암 가능물질로 세계적 관심의 대상 물질이 되고 있다. 국제암연구소(IARC)는 최근 벤조피렌을 그룹 1의 인체 발암 물질로 등급을 상향조정하였다.Benzopyrene has a longer residence period and is more toxic, making it more problematic. It is an endocrine disruptor and a carcinogen, and is a globally targeted substance. The International Cancer Institute (IARC) recently upgraded benzopyrene as a human carcinogen in Group 1.
식품 분야에서도 벤조피렌 문제가 발생하고 있는데 최근 국내에서도 가열처리하는 홍삼 또는 흑삼 등 가공인삼 제품에서 벤조피렌이 검출되어 이를 저감시키는 기술에 대한 관심이 높아지고 있다.In the food field, a problem of benzopyrene is occurring. Recently, in Korea, interest in technology for reducing and detecting benzopyrene in processed ginseng products such as red ginseng or black ginseng has increased.
우리나라에서는 인삼류 중에서 흑삼(분말 포함)은 벤조피렌 기준치를 2.0ppb 이하, 흑삼농축액은 4.0ppb 이하로 규정하고 있으며, 흑홍삼과 흑삼 등 열을 가하여 제조하는 가공삼의 경우 찌는 과정 및 건조 과정을 거치면서 다양한 진세노사이드의 함량이 어느 정도 증가될 수는 있지만 유효하지 않은 성분인 벤조피렌이 기준치를 초과하게 되기 때문에 안전성이 문제가 되고 있다.In Korea, black ginseng (including powder) is defined as less than 2.0ppb of benzopyrene and less than 4.0ppb of black ginseng concentrate among ginsengs.In the case of processed ginseng manufactured by applying heat, such as black red ginseng and black ginseng, during the steaming process and drying process, Although the content of various ginsenosides may be increased to some extent, safety is a problem because the benzopyrene, an ineffective component, exceeds the reference value.
따라서 흑홍삼 또는 흑삼 등의 가공삼 제조시에 유효 성분인 진세노사이드 함량을 증가 시키면서 기준치 보다 적은 벤조피렌 함량을 갖는 제조방법은 여전히 개발 중에 있다. Therefore, the production method of increasing the content of ginsenosides, which is an active ingredient in manufacturing processed ginseng such as black red ginseng or black ginseng, and having a benzopyrene content less than the reference value is still under development.
대한민국 등록특허공보 등록번호 제10-1070770호에는 인삼이 아닌 홍삼 또는 흑삼 등 인삼가공제품을 효소처리 및 동결건조 함으로써 벤조피렌 함량을 감소시키는 방법을 개시하고 있으며, 또한, 대한민국 등록특허공보 등록번호 제10-0805852호에는 인삼을 유기산 용매에 침전시킨 후 감압처리 하는 단계를 포함하여 특정 진세노사이드(Rg1, Rc, Re)가 강화된 홍삼의 제조방법이 개시되어 있다.Republic of Korea Patent Registration No. 10-1070770 discloses a method of reducing benzopyrene content by enzymatic treatment and freeze-drying of ginseng processed products such as red ginseng or black ginseng, and also, Republic of Korea Patent Registration No. 10 -0805852 discloses a method for preparing red ginseng having a specific ginsenoside (Rg1, Rc, Re) reinforcement, including the step of precipitating ginseng in an organic acid solvent followed by depressurization.
한편, 진세노사이드는 인체 대사과정 중 고분자 진세노사이드가 저분자 진세노사이드나 사포닌 대사물로 전환되어 흡수되는데, 흑삼은 인삼, 홍삼에 함유된 고분자 진세노사이드(Rg1, Rb1 등)를 흡수하기 쉬운 형태의 저분자 진세노사이드나 사포닌 대사물로 바꿔 흡수율을 높일 수 있어, 인삼 또는 홍삼을 장기간 복용해야 효과를 볼 수있는 단점을 보완 할 수 있다.On the other hand, ginsenosides are converted into low molecular ginsenosides or saponin metabolites and absorbed by polymer ginsenosides during human metabolism, and black ginseng absorbs polymer ginsenosides (Rg1, Rb1, etc.) contained in ginseng and red ginseng. It can be easily replaced with a low-molecular-weight ginsenoside or a saponin metabolite to increase the absorption rate, so it can compensate for the disadvantages of taking ginseng or red ginseng for a long time.
이에, 본 발명자들은 새로운 접근의 흑삼 제조방법에 대한 연구에 주목하였으며, 인삼의 가공공정이 길어지면 길어질수록 다량 발생되는 벤조피렌의 함량을 기준치 이하로 나타내며, 인삼의 유효성분인 저분자 진세노사이드(F2, Rg3, Rg5, Rk1)의 함량을 극대화 시키면서 기존의 증숙과 건조를 반복하는 과정이 아닌 경제적으로도 대량생산이 가능한 흑삼의 새로운 제조방법을 발견하고 본 발명을 완성하였다.Accordingly, the present inventors paid attention to the research on a new approach to the production of black ginseng, and the longer the processing process of ginseng becomes, the more the content of benzopyrene generated in a large amount is below a standard value, and the low molecular weight ginsenoside (F2) which is an active ingredient of ginseng. , Rg3, Rg5, Rk1) while maximizing the contents, and discovering a new manufacturing method of black ginseng that can be mass-produced economically rather than repeating the existing steaming and drying, and completed the present invention.
본 발명은 저분자 진세노사이드 FRh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 및 Rk1을 높은 함량으로 함유하고, 인삼을 증숙시키는 과정 중에 생성되는 벤조피렌 함량은 기준치 이하로 저감시킨 흑삼의 제조방법을 제공하는 것을 목적으로 한다.The present invention is a low molecular ginsenoside FRh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 and Rk1 containing a high content, the benzopyrene content generated during the process of steaming ginseng reduced the production method of black ginseng reduced below the standard value It aims to provide.
상기와 같은 목적을 달성하기 위하여, 본 발명은 a) 인삼을 건조시키는 단계;In order to achieve the above object, the present invention comprises the steps of a) drying ginseng;
b) 상기 건조된 인삼을 팽화시키는 단계;b) swelling the dried ginseng;
c) 상기 팽화된 인삼을 레몬산 수용액, 매실산 수용액 및 이들의 혼합 수용액으로 이루어진 군으로부터 선택된 산 수용액에 침지시키는 단계;c) immersing the swollen ginseng in an aqueous acid solution selected from the group consisting of an aqueous lemon acid solution, an aqueous plum acid solution and a mixed aqueous solution thereof;
d) 상기 침지된 인삼을 증숙시키는 단계; 및d) steaming the immersed ginseng; And
e) 상기 증숙시킨 인삼을 건조하는 단계를 포함하는, 벤조피렌의 생성은 저감시키고, 진세노사이드 Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 및 Rk1의 함량은 증가시킨 흑삼의 제조방법을 제공한다. e) comprising the step of drying the steamed ginseng, the production of benzopyrene is reduced, and the content of ginsenosides Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 and Rk1 is increased to provide a method for producing black ginseng do.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 a) 단계는 40~60℃의 온도에서 10~18시간 동안 수행되는 것을 특징으로 한다.In the method for manufacturing black ginseng according to the present invention, the step a) is characterized in that it is performed for 10-18 hours at a temperature of 40-60 ° C.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 b) 단계는 압력 2.0~3.0 kgf/cm2에서 수행되는 것을 특징으로 한다. In the method of manufacturing black ginseng according to the present invention, step b) is characterized in that it is performed at a pressure of 2.0 to 3.0 kgf / cm 2 .
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 산 수용액은 pH 2.0~4.0의 범위를 만족하는 것을 특징으로 한다.In the production method of black ginseng according to the present invention, the acid aqueous solution is characterized in that it satisfies the range of pH 2.0-4.0.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 레몬산 수용액은 레몬 추출 원액과 증류수를 4:6 내지 6:4의 비율로 혼합하는 것을 특징으로 한다.In the production method of black ginseng according to the present invention, the aqueous solution of lemon acid is characterized in that the mixture of lemon extract and distilled water is mixed at a ratio of 4: 6 to 6: 4.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 매실산 수용액은 매실 추출 원액과 증류수를 4:6 내지 6:4의 비율로 혼합하는 것을 특징으로 한다.In the production method of black ginseng according to the present invention, the aqueous solution of plum acid is characterized by mixing the extract of plum and distilled water in a ratio of 4: 6 to 6: 4.
상기 산 수용액은 레몬산 수용액과 매실산 수용액을 1:3 내지 3:1의 비율로 혼합하는 것을 특징으로 한다.The acid aqueous solution is characterized in that the aqueous solution of lemon acid and the aqueous solution of plum acid are mixed in a ratio of 1: 3 to 3: 1.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 산 수용액은 pH 2.0 내지 2.5를 만족하는 것일 수 있으며, 보다 바람직하게는 pH 2.0인 것을 특징으로 한다.In the production method of black ginseng according to the present invention, the aqueous acid solution may be one that satisfies pH 2.0 to 2.5, and more preferably, is pH 2.0.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 d) 단계는 70~90℃의 온도에서 6~10 시간 동안 수행되는 것을 특징으로 한다.In the method of manufacturing black ginseng according to the present invention, the step d) is characterized in that it is carried out for 6 to 10 hours at a temperature of 70 ~ 90 ℃.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 d) 단계는 70~90℃의 온도에서 8 시간 동안 수행되는 것을 특징으로 한다.In the method of manufacturing black ginseng according to the present invention, the step d) is characterized in that it is performed for 8 hours at a temperature of 70 ~ 90 ℃.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 e) 단계는 50~70℃의 온도에서 수행되는 것을 특징으로 한다.In the manufacturing method of black ginseng according to the present invention, the step e) is characterized in that it is carried out at a temperature of 50 ~ 70 ℃.
본 발명에 따른 흑삼의 제조방법에 있어서, 상기 벤조피렌은 0.5 ppb 이하의 함량으로 생성된 것을 특징으로 한다.In the method of manufacturing black ginseng according to the present invention, the benzopyrene is characterized in that it is produced in an amount of 0.5 ppb or less.
본 발명은 또한, 상기 흑삼의 제조방법에 의하여 제조된 흑삼을 제공한다.The present invention also provides black ginseng prepared by the method for producing black ginseng.
상기 제조된 흑삼은 진세노사이드 중 Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 및 Rk1의 함량이 증가된 것을 특징으로 한다. The prepared black ginseng is characterized by an increased content of Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 and Rk1 among ginsenosides.
아울러, 상기 제조된 흑삼은 벤조피렌을 0.5 ppb 이하로 함유하는 것을 특징으로 한다. In addition, the prepared black ginseng is characterized in that it contains less than 0.5 ppb benzopyrene.
본 발명에 따른 흑삼의 제조방법은 진세노사이드 Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 및 Rk1의 함량은 증가시킨 동시에 인체에 유해한 벤조피렌의 함량은 저감시킴으로써, 이를 적용한 흑삼 가공식품은 생체 효능을 높일 수 있고, 장기간 복용하더라도 안전하게 복용할 수 있다.The production method of black ginseng according to the present invention increases the content of ginsenosides Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 and Rk1 while reducing the amount of benzopyrene harmful to the human body, and the processed black ginseng processed food is bio Efficacy can be increased, and can be safely taken even if taken for a long time.
이하에서는, 본 발명에 따른 바람직한 실시예를 보다 상세하게 설명하기로 한다.Hereinafter, a preferred embodiment according to the present invention will be described in more detail.
본 발명 설명에 앞서, 이하의 특정한 구조 내지 기능적 설명들은 단지 본 발명의 개념에 따른 실시예를 설명하기 위한 목적으로 예시된 것으로, 본 발명의 개념에 따른 실시예들은 다양한 형태로 실시될 수 있으며, 본 명세서에 설명된 실시예들에 한정되는 것으로 해석되어서는 아니된다.Prior to the description of the present invention, the following specific structures or functional descriptions are merely exemplified for the purpose of illustrating the embodiments according to the concept of the present invention, and the embodiments according to the concept of the present invention may be implemented in various forms, It should not be construed as being limited to the embodiments described herein.
또한, 본 발명의 개념에 따른 실시예는 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있으므로, 특정 실시예들은 본 명세서에 상세하게 설명하고자 한다. 그러나, 이는 본 발명의 개념에 따른 실시예들을 특정한 개시 형태에 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경물, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.In addition, embodiments according to the concept of the present invention can be applied to various changes and may have various forms, so specific embodiments will be described in detail herein. However, this is not intended to limit the embodiments according to the concept of the present invention to a specific disclosure form, and it should be understood to include all modifications, equivalents, and substitutes included in the spirit and scope of the present invention.
실시예 1 내지 5. 흑삼의 제조Examples 1 to 5. Preparation of black ginseng
4년근 이상의 인삼(뿌리, 줄기, 잎 등)을 40~60℃의 온도에서 약10~18시간 동안 건조시켜, 인삼 내 수분 함유량이 30% 이하가 되게 하였다. 상기 건조된 인삼을 회전식 팽화기에 넣고, 팽화기의 압력이 2.5 kgf/cm2 에 도달할 때까지 팽화시켰다. 이어서, 상기 팽화된 인삼을 pH 2.0 내지 3.0 인 매실산, 레몬산 및 이들의 혼합물로 이루어진 군으로부터 선택되는 1종의 수용액에 30분간 침지시킨 후, 80℃의 온도에서 8시간 동안 증숙시켰다. 상기 증숙된 인삼을 60℃의 온도에서 8시간 건조하여 흑삼을 제조하였다.Ginseng (root, stem, leaf, etc.) over 4 years old was dried at a temperature of 40 ~ 60 ℃ for about 10 ~ 18 hours, so that the moisture content in the ginseng became 30% or less. The dried ginseng was put in a rotary inflator, and inflated until the pressure of the inflator reached 2.5 kgf / cm 2 . Subsequently, the swollen ginseng was immersed for 30 minutes in one aqueous solution selected from the group consisting of plum acid, lemon acid and mixtures thereof having a pH of 2.0 to 3.0, and then steamed for 8 hours at a temperature of 80 ° C. The steamed ginseng was dried at a temperature of 60 ° C. for 8 hours to prepare black ginseng.
실시예 1 내지 5 및 비교예 1 내지 3의 공정 조건을 하기 표 1에 정리하여 나타내었다. The process conditions of Examples 1 to 5 and Comparative Examples 1 to 3 are summarized in Table 1 below.
비교예Comparative example 1 내지 3. 1 to 3.
상기 실시예에서 매실산 또는 레몬산을 대신하여 구연산, 사과산 및 아스코르브산으로부터 선택된 산 수용액을 사용하는 것을 제외하고는, 상기 실시예의 방법과 동일하게 하여 흑삼을 제조하였다. Black ginseng was prepared in the same manner as in the above example, except that an acid aqueous solution selected from citric acid, malic acid, and ascorbic acid was used in place of plum acid or lemon acid.
실험예 1. 진세노사이드 함량 분석Experimental Example 1. Ginsenoside content analysis
본 발명의 실시예 1 내지 2 및 비교예 1 의 방법으로 제조된 흑삼을 대상으로 진세노사이드 성분을 측정하였다. Ginsenoside components were measured on black ginseng prepared by the methods of Examples 1 to 2 and Comparative Example 1 of the present invention.
구체적으로는 메탄올 100㎖ 용매에 각 실시예 및 비교예에서 제조된 흑삼 분말 1g을 달아 50℃에서 15분간 초음파 추출하여 추출하였다. 상등액을 여과하였고 다시 여액을 상기와 같은 방법으로 2회 반복 추출하여 3차례 추출로 수득한 상등액을 모아 감압농축한 후 증류수 5㎖에 녹였다. 메탄올 2㎖과 증류수 5㎖로 미리 활성화시킨 카트리지에 샘플농축액을 로딩하고 증류수 5㎖와 30% 메탄올 5㎖로 세척한 후 메탄올 2㎖로 진세노사이드 성분을 회수하였다. 회수된 진세노사이드 성분액을 0.45㎛ 필터로 여과한 후 HPLC로 분석하였다. 이때 대조예로서 4년근 이상의 건조된 인삼을 사용하였다. 구체적인 HPLC 분석 조건은 하기 표 2에 정리하여 나타내었다. Specifically, 1 g of black ginseng powder prepared in each Example and Comparative Example was added to a 100 ml methanol solvent, and extracted by ultrasonic extraction at 50 ° C. for 15 minutes. The supernatant was filtered and the filtrate was repeatedly extracted twice in the same manner as above to collect the supernatant obtained by extraction three times, concentrated under reduced pressure, and dissolved in 5 ml of distilled water. The sample concentrate was loaded into a cartridge previously activated with 2 ml of methanol and 5 ml of distilled water, washed with 5 ml of distilled water and 5 ml of 30% methanol, and then the ginsenoside component was recovered with 2 ml of methanol. The recovered ginsenoside component was filtered through a 0.45 μm filter and analyzed by HPLC. At this time, dried ginseng over 4 years old was used as a control example. Specific HPLC analysis conditions are summarized in Table 2 below.
상기 분석 조건을 통해 분석된 각각의 실시예 1 내지 2 및 비교예 1에서 제조된 흑삼 분말에 대한 진세노사이드(Rf, Rh1, Rh2, Rc, Rb2, Rb3, Rd, F2, Rg3, PPT, K, Rh2, Rk1)의 함량을 하기 표 3에 나타내었다.Ginsenosides (Rf, Rh1, Rh2, Rc, Rb2, Rb3, Rd, F2, Rg3, PPT, K) for the black ginseng powders prepared in Examples 1 to 2 and Comparative Example 1 analyzed through the above analysis conditions , Rh2, Rk1) are shown in Table 3 below.
상기 표 3에서 알 수 있는 바와 같이, 본 발명에 따른 실시예 1 내지 2에서 제조된 흑삼의 진세노사이드(Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3, Rk1) 함량은 비교예 1 대비 전체적으로 증가한 결과를 보여준다. 특히, 저분자 진세노사이드 F2의 경우, 비교예 1보다 약 10% 가량 함량이 증가한 것을 볼 수 있다. As can be seen from Table 3, the ginsenosides (Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3, Rk1) of black ginseng prepared in Examples 1 to 2 according to the present invention are compared to Comparative Example 1 Overall increase results are shown. In particular, in the case of low molecular ginsenoside F2, it can be seen that the content increased by about 10% compared to Comparative Example 1.
또한, 실시예 1과 실시예 2를 비교를 통해, pH 3.0의 매실산 수용액보다 2.0의 매실산 수용액을 사용하는 경우, 보다 진세노사이드의 함량을 증가시키는 것을 확인할 수 있다. In addition, through comparison of Example 1 and Example 2, when using a 2.0 aqueous solution of plum acid than the aqueous solution of plum acid of pH 3.0, it can be confirmed that the content of ginsenoside is increased.
실험예 2. 벤조피렌 함량 분석Experimental Example 2. Analysis of benzopyrene content
흑삼의 제조과정에서 생성되는 유해한 성분인 벤조피렌의 함량을 확인하기 위하여, 본 발명의 실시예 1 내지 5의 제조방법에 의하여 제조된 흑삼의 벤조피렌의 함량을 측정하였다. 구체적인 측정 조건은 하기 표 4에 나타내었다. In order to confirm the content of benzopyrene, which is a harmful component produced during the manufacturing process of black ginseng, the content of benzopyrene of black ginseng produced by the manufacturing methods of Examples 1 to 5 of the present invention was measured. Specific measurement conditions are shown in Table 4 below.
구체적인 측정방법은 다음과 같다. 증류수 100㎖에 흑삼 분말 5g을 달아 50℃에서 90분간 초음파 추출하였다. 여기에 핵산 100㎖ 및 내부표준액(3-메틸콜란트렌의 아세토니트릴 용액(50㎍/L)) 1㎖을 넣고 30분간 초음파추출한 후, 핵산층을 분액 깔때기에 취하였다. 다시 물층을 핵산 50㎖로 진탕추출 2회 한 후 핵산층을 분액 갈때기에 합한 후, 합한 핵산층을 증류수 50㎖로 세척하였다. 상기 핵산층을 무수 황산나트륨을 넣은 여과지를 사용하여 탈수 여과한 다음 45℃의 수욕상에서 감압 (약 700mbar)하여 핵산 약 2ml가 될 때까지 농축하였다. 플로리실 카트리지는 미리 디클로로메탄 10㎖ 및 핵산 20㎖를 순서대로 초당 2 ~ 3방울의 속도로 유출시켜 활성화시킨 후 사용하였다. 활성화된 카트리지에 상 기의 추출용액을 넣어 핵산, 디클로로메탄혼합액(3:1) 20㎖를 초당 2~3방울 속도로 용출시켰다. 이 용출된 액을 35℃이하의 수욕상에서 질소가스 하에 날려 보낸 후 잔류물을 아세토니트릴 1㎖에 녹인 다음 공경 0.45㎛이하의 멤브레인필터로 여과하여 검액으로 하였다. 따로 벤조피렌 표준품 및 3-메틸콜란트렌 표준품 적당량을 정밀하게 달아 각각 아세토니트릴에 녹여 ㎖당 1㎍을 함유하는 표준원액 및 내부표준원액을 만들었다. 검액 및 표준액 10㎕씩을 가지고 HPLC로 분석하고, 그 결과를 하기 표 5에 나타내었다.The specific measuring method is as follows. 5 g of black ginseng powder was added to 100 ml of distilled water and ultrasonic extraction was performed at 50 ° C for 90 minutes. To this, 100 ml of nucleic acid and 1 ml of an internal standard solution (acetonitrile solution of 3-methylcholantran (50 μg / L)) were added and ultrasonically extracted for 30 minutes, and then the nucleic acid layer was taken in a separatory funnel. After the water layer was shaken twice with 50 ml of nucleic acid, the nucleic acid layer was combined with a separator, and the combined nucleic acid layer was washed with 50 ml of distilled water. The nucleic acid layer was dehydrated using a filter paper containing anhydrous sodium sulfate and then concentrated under reduced pressure (about 700 mbar) in a water bath at 45 ° C. until it became about 2 ml of nucleic acid. The Florisil cartridge was used after 10 ml of dichloromethane and 20 ml of nucleic acid were sequentially activated by flowing at a rate of 2-3 drops per second. 20 ml of nucleic acid and dichloromethane mixture (3: 1) were eluted at a rate of 2-3 drops per second by putting the above extraction solution in the activated cartridge. The eluted solution was blown under nitrogen gas in a water bath below 35 ° C., and the residue was dissolved in 1 ml of acetonitrile, filtered through a membrane filter having a pore size of 0.45 μm or less to obtain a sample solution. Separately, the appropriate amounts of benzopyrene standard and 3-methylcholenrene standard were precisely weighed and dissolved in acetonitrile to prepare a standard stock solution and an internal standard stock solution containing 1 µg per ml. 10 μl of the sample solution and the standard solution were analyzed by HPLC, and the results are shown in Table 5 below.
표 5에서 볼 수 있는 바와 같이, 본 발명의 실시예 1 내지 4의 제조방법에 의하여 제조된 흑삼의 벤조피렌 함량은 기준치(2.0 ppb) 이하보다 현저히 저감된 것을 확인할 수 있다.As can be seen in Table 5, it can be seen that the benzopyrene content of black ginseng prepared by the production methods of Examples 1 to 4 of the present invention was significantly reduced than the reference value (2.0 ppb) or less.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. So far, the present invention has been focused on the preferred embodiments. Those skilled in the art to which the present invention pertains will understand that the present invention can be implemented in a modified form without departing from the essential characteristics of the present invention.
Claims (15)
b) 상기 건조된 인삼을 팽화시키는 단계;
c) 상기 팽화된 인삼을 레몬산 수용액, 매실산 수용액 및 이들의 혼합 수용액으로 이루어진 군으로부터 선택된 산 수용액에 침지시키는 단계;
d) 상기 침지된 인삼을 증숙시키는 단계; 및
e) 상기 증숙시킨 인삼을 건조하는 단계를 포함하는, 벤조피렌의 생성은 저감시키고, 진세노사이드 Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 및 Rk1의 함량은 증가시킨 흑삼의 제조방법.
a) drying ginseng;
b) swelling the dried ginseng;
c) immersing the swollen ginseng in an aqueous acid solution selected from the group consisting of an aqueous lemon acid solution, an aqueous plum acid solution and a mixed aqueous solution thereof;
d) steaming the immersed ginseng; And
e) comprising the step of drying the steamed ginseng, the production of benzopyrene is reduced, the content of ginsenosides Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 and Rk1 increased black ginseng production method.
상기 a) 단계는 40~60℃의 온도에서 10~18시간 동안 수행되는 것인 흑삼의 제조방법.
According to claim 1,
The a) step is a method of producing black ginseng that is performed for 10 to 18 hours at a temperature of 40 to 60 ℃.
상기 b) 단계는 압력 2.0~3.0 kgf/cm2에서 수행되는 것인 흑삼의 제조방법.
According to claim 1,
The step b) is a method of producing black ginseng that is performed at a pressure of 2.0 to 3.0 kgf / cm 2 .
상기 산 수용액은 pH 2.0~4.0의 범위를 만족하는 것인 흑삼의 제조방법.
According to claim 1,
The acid aqueous solution is a method of producing black ginseng that satisfies the range of pH 2.0 to 4.0.
상기 레몬산 수용액은 레몬 추출 원액과 증류수를 4:6 내지 6:4의 비율로 혼합한 것인 흑삼의 제조방법.
According to claim 1,
The lemon acid aqueous solution is a method of producing black ginseng, which is a mixture of lemon extract and distilled water in a ratio of 4: 6 to 6: 4.
상기 매실산 수용액은 매실 추출 원액과 증류수를 4:6 내지 6:4의 비율로 혼합한 것인 흑삼의 제조방법.
According to claim 1,
The aqueous solution of plum acid is a method of producing black ginseng, which is a mixture of plum extract and distilled water in a ratio of 4: 6 to 6: 4.
상기 산 수용액은 레몬산 수용액과 매실산 수용액을 1:3 내지 3:1의 비율로 혼합한 것인 흑삼의 제조방법.
According to claim 1,
The acid aqueous solution is a method of producing black ginseng in which the aqueous solution of lemon acid and the aqueous solution of plum acid are mixed in a ratio of 1: 3 to 3: 1.
상기 수용액은 pH 2.0 내지 2.5를 만족하는 것인 흑삼의 제조방법.
The method of claim 5 to 7,
The aqueous solution is a method of producing black ginseng that satisfies the pH 2.0 to 2.5.
상기 d) 단계는 70~90℃의 온도에서 6~10 시간 동안 수행되는 것인 흑삼의 제조방법.
According to claim 1,
The d) step is a method of producing black ginseng that is performed for 6 to 10 hours at a temperature of 70 ~ 90 ℃.
상기 d) 단계는 70~90℃의 온도에서 8 시간 동안 수행되는 것인 흑삼의 제조방법.
According to claim 1,
The d) step is a method of producing black ginseng that is performed for 8 hours at a temperature of 70 ~ 90 ℃.
상기 e) 단계는 50~70℃의 온도에서 수행되는 것인 흑삼의 제조방법.
According to claim 1,
The e) step is a method of producing black ginseng that is performed at a temperature of 50 ~ 70 ℃.
상기 벤조피렌은 0.5 ppb 이하의 함량으로 생성된 것인 흑삼의 제조방법.
According to claim 1,
The benzopyrene is a production method of black ginseng that is produced in an amount of 0.5 ppb or less.
Black ginseng prepared by the method of any one of claims 1 to 12.
The black ginseng of claim 13 is a black ginseng having an increased content of Rh1, Rh2, Rg2, Rb1, Rb2, F2, Rg3 and Rk1 among ginsenosides.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180115177A KR20200035715A (en) | 2018-09-27 | 2018-09-27 | The manufacturing process of the black-ginseng comprising high ginsenoside content |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180115177A KR20200035715A (en) | 2018-09-27 | 2018-09-27 | The manufacturing process of the black-ginseng comprising high ginsenoside content |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200035715A true KR20200035715A (en) | 2020-04-06 |
Family
ID=70282134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180115177A KR20200035715A (en) | 2018-09-27 | 2018-09-27 | The manufacturing process of the black-ginseng comprising high ginsenoside content |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200035715A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220065231A (en) | 2020-11-13 | 2022-05-20 | 재단법인 금산인삼약초산업진흥원 | Puffed black ginseng And Manufacturing method thereof |
-
2018
- 2018-09-27 KR KR1020180115177A patent/KR20200035715A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220065231A (en) | 2020-11-13 | 2022-05-20 | 재단법인 금산인삼약초산업진흥원 | Puffed black ginseng And Manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101507652B1 (en) | The manufacturing process of the black-ginseng comprising high ginsenoside content | |
KR101597853B1 (en) | Method for producing a composition with a high content of sapogenin | |
KR101373252B1 (en) | Process for Preparing Fermented Power Tea from Unpolished Rice and Guava Leaves | |
Peng et al. | Changes in levels of phenylethanoid glycosides, antioxidant activity, and other quality traits in Cistanche deserticola slices by steam processing | |
KR20190112498A (en) | Whole Ginseng Composition Using Ginseng Roots, Leaves and Berries and Method of Preparing the Same | |
KR20100043725A (en) | Changes of protopanaxadiol ginsenosides in ginseng leaves by steaming heat treatment | |
KR100517128B1 (en) | An extraction method of physiologically active in ginseng or red ginseng | |
KR20200035715A (en) | The manufacturing process of the black-ginseng comprising high ginsenoside content | |
KR101862834B1 (en) | A preparing mehod of puffed ginseng with excellent taste and functionality using ginseng berry | |
KR102115669B1 (en) | Preparation method of black Platycodon grandiflorus having increased crude saponin and reduced Platycodin D, inhibiting production of benzopyrene | |
KR101068216B1 (en) | Method for producing dried ginseng with increased red ginseng components using far-infrared irradiation | |
KR102411104B1 (en) | Method for producing ginseng concentrate using plate evaporation concentration technology | |
KR20100043723A (en) | Changes of protopanaxadiol ginsenosides in ginseng leaves by far infrared heat treatment | |
KR20170073124A (en) | Antioxidant composition and methods of manufacturing for according to steaming conditions of Platycodon grandiflorum Stems | |
KR102295116B1 (en) | Manufacturing method of black ginseng to improve cognitive function and black ginseng manufactured by the method | |
KR101336646B1 (en) | Ginsenoside Rg2, Rg3 and Rh1-enriched Tae-Guek ginseng and producing method thereof | |
KR101123642B1 (en) | Method for manufacturing the ginseng extrat having the reduced gineng flavor and bitter taste | |
KR101833328B1 (en) | A preparing mehod of puffed ginseng with excellent taste and functionality by pre-treatment process | |
KR101097664B1 (en) | Method of processing roots of korea ginseng | |
CN112546077A (en) | Combined extraction method and application of hypoglycemic substances in phellinus igniarius | |
KR101921507B1 (en) | Manufacturing of a black ginseng increased saponin contents | |
CN111011562A (en) | Aralia elata health tea and preparation method thereof | |
KR101084416B1 (en) | Production of Dried Ginseng with Increased Antioxidant Activity Using Far-infrared | |
KR102627124B1 (en) | Manufacturing method of Jelly Stick using Wood Cultivated Ginseng | |
KR102665525B1 (en) | The method and the extract of extracting ginsenosides from red ginseng or black ginseng, manufactured using ultra-high pressure treatment, using high-temperature and high-pressure water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E601 | Decision to refuse application |